Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: Effects of pollen exposure and nasal glucocorticoid treatment

Allergy, Asthma and Clinical Immunology

Volumn 6, Issue 1, 2010, Pages

  O'Neil, Serena E ^a   Malmhäll, Carina ^a   Samitas, Konstantinos ^b   Pullerits, Teet ^a   Bossios, Apostolos ^a   Lötvall, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Hospital for Diseases of the Chest SOTIRIA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; OSTEOPONTIN;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; EOSINOPHILIA; EPITHELIUM CELL; GRASS POLLEN; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; NASAL BIOPSY; NOSE MUCOSA; POLLEN ALLERGY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE DISTRIBUTION;

EID: 82755186334     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-6-28     Document Type: Article

References (18)

1. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. Skoner DP, J Allergy Clin Immunol 2001 108 2 8 10.1067/mai.2001.115569 11449200 (Pubitemid 32678751)
2. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. Pullerits T, Praks L, Ristioja V, Lotvall J, J Allergy Clin Immunol 2002 109 949 955 10.1067/mai.2002.124467 12063523 (Pubitemid 34634304)
3. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge. Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, Murdoch RD, Durham SR, Barnes PJ, Hansel TT, Clin Exp Allergy 2005 35 1608 1614 10.1111/j.1365-2222.2005.02381.x 16393327
4. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge. Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W, J Allergy Clin Immunol 2001 107 627 633 10.1067/mai.2001.113520 11295650 (Pubitemid 32397749)
5. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. Malmhall C, Bossios A, Pullerits T, Lotvall J, Allergy 2007 62 1007 1013 10.1111/j.1398-9995.2007.01420.x 17686103 (Pubitemid 47220970)
6. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid. Sergejeva S, Malmhall C, Lotvall J, Pullerits T, Clin Exp Allergy 2005 35 34 38 10.1111/j.1365-2222.2004.02038.x 15649263 (Pubitemid 40188267)
7. The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems. Kunii Y, Niwa S, Hagiwara Y, Maeda M, Seitoh T, Suzuki T, Med Mol Morphol 2009 42 155 161 10.1007/s00795-009-0459-6 19784742
8. The role of osteopontin in inflammatory processes. Lund SA, Giachelli CM, Scatena M, J Cell Commun Signal 2009 3 311 322 10.1007/s12079-009-0068-0 19798593
9. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Kohan M, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N, Clin Exp Allergy 2007 37 1444 1454 17883724 (Pubitemid 47460229)
10. Osteopontin is involved in migration of eosinophils in asthma. Takahashi A, Kurokawa M, Konno S, Ito K, Kon S, Ashino S, Nishimura T, Uede T, Hizawa N, Huang SK, Nishimura M, Clin Exp Allergy 2009 39 1152 1159 10.1111/j.1365-2222. 2009.03249.x 19400906
11. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, Lambrecht BN, Lloyd CM, Panoutsakopoulou V, Nat Med 2007 13 570 578 10.1038/nm1580 17435770 (Pubitemid 46828486)
12. Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps. Lu X, Zhang XH, Wang H, Long XB, You XJ, Gao QX, Cui YH, Liu Z, Allergy 2009 64 104 111 10.1111/j.1398-9995.2008.01829.x 19076536
13. Osteopontin is expressed and functional in human eosinophils. Puxeddu I, Berkman N, Ribatti D, Bader R, Haitchi HM, Davies DE, Howarth PH, Levi-Schaffer F, Allergy 2010 65 168 174 10.1111/j.1398-9995.2009.02148.x 19804447
14. Effects of corticosteroids on osteopontin expression in a murine model of allergic asthma. Kurokawa M, Konno S, Matsukura S, Kawaguchi M, Ieki K, Suzuki S, Odaka M, Watanabe S, Homma T, Sato M, Takeuchi H, Hirose T, Huang SK, Adachi M, Int Arch Allergy Immunol 2009 149 Suppl 1 7 13 10.1159/000210647 19494498
15. Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C, Am J Respir Crit Care Med 2009 179 894 902 10.1164/rccm.200807-1081OC 19234104
16. Osteopontin expression and relation to disease severity in human asthma. Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, Gogos H, Economidou E, Lotvall J, Xanthou G, Panoutsakopoulou V, Gaga M, Eur Respir J 2010 20562127
17. Osteopontin: role in immune regulation and stress responses. Wang KX, Denhardt DT, Cytokine Growth Factor Rev 2008 19 333 345 10.1016/j.cytogfr.2008. 08.001 18952487
18. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Shinohara ML, Lu L, Bu J, Werneck MB, Kobayashi KS, Glimcher LH, Cantor H, Nat Immunol 2006 7 498 506 10.1038/ni1327 16604075